Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Fluorescence microlymphography: diagnostic potential in lymphedema and basis for the measurement of lymphatic pressure and flow velocity.

Identifieur interne : 007266 ( Main/Exploration ); précédent : 007265; suivant : 007267

Fluorescence microlymphography: diagnostic potential in lymphedema and basis for the measurement of lymphatic pressure and flow velocity.

Auteurs : A. Bollinger [Suisse] ; B R Amann-Vesti

Source :

RBID : pubmed:17853615

Descripteurs français

English descriptors

Abstract

Fluorescence microlymphography (FML) is an almost atraumatic technique used to visualize the superficial skin network of initial lymphatics through the intact skin of man. Visualization was performed with an incident light fluorescence microscope following subepidermal injection of minute amounts of FITC-dextran 150,000 using microneedles. Emanating from the bright dye depot, the surrounding network of microvessels is filled, documentation performed by photography or video film. In congenital Milroy lymphedema, a lack of microlymphatics (aplasia) is typical while in other primary lymphedemas and in secondary lymphedema after mastectomy or irradiation of proximal lymph nodes, the network remains intact but the depicted area is enlarged. Lymphatic microangiopathy characterized by obliterations of capillary meshes or mesh segments develops in phleboedema with trophic skin changes, progressive systemic sclerosis and Fabry's disease. In lipedema, lymphatic microaneurysms are stained. Microlymphatic pressure may also be measured using FML. For this purpose, glass micropipettes are inserted into the capillaries by means of a micromanipulator and pressure is determined by the servo-nulling technique. Normal subjects produced significantly lower pressure (7.9 +/- 3.4 mmHg) compared to patients with primary lymphedema (15.0 +/- 5.1 mmHg, p<0.001). This characteristic lymphatic hypertension may be improved by complex physiotherapy or local application of prostaglandins. Additionally, a modification of the FML procedure can be used to measure lymphatic capillary flow velocity in controls and patients. FML is suited to confirm the clinical diagnosis of lymphedema, contributes to distinguish among various forms of edema, and is useful in clinical research. In addition, FML has also become a tool for experimental animal studies including the depiction of gastric microlymphatics, the measurement of flow velocity in the naked mouse tail, and in evaluation of lymphangiogenesis in a model of Milroy disease.

PubMed: 17853615


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Fluorescence microlymphography: diagnostic potential in lymphedema and basis for the measurement of lymphatic pressure and flow velocity.</title>
<author>
<name sortKey="Bollinger, A" sort="Bollinger, A" uniqKey="Bollinger A" first="A" last="Bollinger">A. Bollinger</name>
<affiliation wicri:level="1">
<nlm:affiliation>Clinic of Angiology, University Hospital of Zurich, Zurich, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Clinic of Angiology, University Hospital of Zurich, Zurich</wicri:regionArea>
<wicri:noRegion>Zurich</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Amann Vesti, B R" sort="Amann Vesti, B R" uniqKey="Amann Vesti B" first="B R" last="Amann-Vesti">B R Amann-Vesti</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2007">2007</date>
<idno type="RBID">pubmed:17853615</idno>
<idno type="pmid">17853615</idno>
<idno type="wicri:Area/PubMed/Corpus">003524</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003524</idno>
<idno type="wicri:Area/PubMed/Curation">003524</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003524</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003524</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003524</idno>
<idno type="wicri:Area/Ncbi/Merge">002900</idno>
<idno type="wicri:Area/Ncbi/Curation">002900</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002900</idno>
<idno type="wicri:doubleKey">0024-7766:2007:Bollinger A:fluorescence:microlymphography:diagnostic</idno>
<idno type="wicri:Area/Main/Merge">007408</idno>
<idno type="wicri:Area/Main/Curation">007266</idno>
<idno type="wicri:Area/Main/Exploration">007266</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Fluorescence microlymphography: diagnostic potential in lymphedema and basis for the measurement of lymphatic pressure and flow velocity.</title>
<author>
<name sortKey="Bollinger, A" sort="Bollinger, A" uniqKey="Bollinger A" first="A" last="Bollinger">A. Bollinger</name>
<affiliation wicri:level="1">
<nlm:affiliation>Clinic of Angiology, University Hospital of Zurich, Zurich, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Clinic of Angiology, University Hospital of Zurich, Zurich</wicri:regionArea>
<wicri:noRegion>Zurich</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Amann Vesti, B R" sort="Amann Vesti, B R" uniqKey="Amann Vesti B" first="B R" last="Amann-Vesti">B R Amann-Vesti</name>
</author>
</analytic>
<series>
<title level="j">Lymphology</title>
<idno type="ISSN">0024-7766</idno>
<imprint>
<date when="2007" type="published">2007</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>Fluorescence</term>
<term>Humans</term>
<term>Lymphatic Diseases (diagnosis)</term>
<term>Lymphatic Diseases (physiopathology)</term>
<term>Lymphatic System (physiopathology)</term>
<term>Lymphatic Vessels (physiopathology)</term>
<term>Lymphedema (diagnosis)</term>
<term>Lymphedema (physiopathology)</term>
<term>Lymphography (instrumentation)</term>
<term>Lymphography (methods)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Animaux</term>
<term>Fluorescence</term>
<term>Humains</term>
<term>Lymphoedème (diagnostic)</term>
<term>Lymphoedème (physiopathologie)</term>
<term>Lymphographie ()</term>
<term>Lymphographie (instrumentation)</term>
<term>Maladies lymphatiques (diagnostic)</term>
<term>Maladies lymphatiques (physiopathologie)</term>
<term>Système lymphatique (physiopathologie)</term>
<term>Vaisseaux lymphatiques (physiopathologie)</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en">
<term>Lymphatic Diseases</term>
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr">
<term>Lymphoedème</term>
<term>Maladies lymphatiques</term>
</keywords>
<keywords scheme="MESH" qualifier="instrumentation" xml:lang="en">
<term>Lymphography</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Lymphography</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr">
<term>Lymphoedème</term>
<term>Maladies lymphatiques</term>
<term>Système lymphatique</term>
<term>Vaisseaux lymphatiques</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en">
<term>Lymphatic Diseases</term>
<term>Lymphatic System</term>
<term>Lymphatic Vessels</term>
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Fluorescence</term>
<term>Humans</term>
</keywords>
<keywords scheme="MESH" qualifier="instrumentation" xml:lang="fr">
<term>Animaux</term>
<term>Fluorescence</term>
<term>Humains</term>
<term>Lymphographie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Fluorescence microlymphography (FML) is an almost atraumatic technique used to visualize the superficial skin network of initial lymphatics through the intact skin of man. Visualization was performed with an incident light fluorescence microscope following subepidermal injection of minute amounts of FITC-dextran 150,000 using microneedles. Emanating from the bright dye depot, the surrounding network of microvessels is filled, documentation performed by photography or video film. In congenital Milroy lymphedema, a lack of microlymphatics (aplasia) is typical while in other primary lymphedemas and in secondary lymphedema after mastectomy or irradiation of proximal lymph nodes, the network remains intact but the depicted area is enlarged. Lymphatic microangiopathy characterized by obliterations of capillary meshes or mesh segments develops in phleboedema with trophic skin changes, progressive systemic sclerosis and Fabry's disease. In lipedema, lymphatic microaneurysms are stained. Microlymphatic pressure may also be measured using FML. For this purpose, glass micropipettes are inserted into the capillaries by means of a micromanipulator and pressure is determined by the servo-nulling technique. Normal subjects produced significantly lower pressure (7.9 +/- 3.4 mmHg) compared to patients with primary lymphedema (15.0 +/- 5.1 mmHg, p<0.001). This characteristic lymphatic hypertension may be improved by complex physiotherapy or local application of prostaglandins. Additionally, a modification of the FML procedure can be used to measure lymphatic capillary flow velocity in controls and patients. FML is suited to confirm the clinical diagnosis of lymphedema, contributes to distinguish among various forms of edema, and is useful in clinical research. In addition, FML has also become a tool for experimental animal studies including the depiction of gastric microlymphatics, the measurement of flow velocity in the naked mouse tail, and in evaluation of lymphangiogenesis in a model of Milroy disease.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Suisse</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Amann Vesti, B R" sort="Amann Vesti, B R" uniqKey="Amann Vesti B" first="B R" last="Amann-Vesti">B R Amann-Vesti</name>
</noCountry>
<country name="Suisse">
<noRegion>
<name sortKey="Bollinger, A" sort="Bollinger, A" uniqKey="Bollinger A" first="A" last="Bollinger">A. Bollinger</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 007266 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 007266 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:17853615
   |texte=   Fluorescence microlymphography: diagnostic potential in lymphedema and basis for the measurement of lymphatic pressure and flow velocity.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:17853615" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024